This is a snippet of the transcript, sign up to read more.
There's an imaging process every few minutes, allowing us to examine them in great detail without disturbing their protected environment. This has accumulated data that we can mine, helping us understand not just embryo development better, but also which embryos and patterns of development are most associated with a healthy pregnancy. This has resulted in the development of selection algorithms and many research papers studying the nuances of embryo development, which can only be a good thing.
This is a snippet of the transcript, sign up to read more.
We've built our own algorithms to predict birth outcomes because we were first movers in the UK and accumulated a lot of data. In the UK, we are obliged to collect birth outcome data, so our dataset is very complete. We've built and validated these algorithms properly with training and validation datasets and prospectively validated them. We know that it is identifying and ranking the best embryos for us better than we could otherwise.
This is a snippet of the transcript, sign up to read more.
We've used the EmbryoScope for many years, and I'd say 90% of our time-lapse devices are EmbryoScope. We've acquired some clinics that have different systems, like the Geri time-lapse incubator. We try to apply our knowledge and learnings from the EmbryoScope to the images and systems from the Geri. It's a challenging exercise, but I believe the human embryo follows a predetermined pathway of development. It doesn't make biological sense that an algorithm built on one image system would be different from another. Technically, there are some challenges in translating, but overall, I think they should be completely compatible.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.